Complete Regression of Established Spontaneous Mammary Carcinoma and the Therapeutic Prevention of Genetically Programmed Neoplastic Transition by IL-12/Pulse IL-2: Induction of Local T Cell Infiltration, Fas/Fas Ligand Gene Expression, and Mammary Epithelial Apoptosis1 2

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Immunology

• Publication date

  2001-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.166.2.1156PMID 11145697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.

  2000cited by this paper
• Anti‐tumor activity of interleukin‐2‐producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system

  1999cited by this paper
• Fas-signaling and effects on receptor tyrosine kinase signal transduction in human breast epithelial cells.

  1997cited by this paper
• Fas/APO‐1 (CD95)‐mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin‐2‐activated T cells

  1997cited by this paper
• Regulated production of the interferon-gamma-inducible protein-10 (IP-10) chemokine by human neutrophils.

  1997cited by this paper
• Regulated production of the interferon‐γ‐inducible protein−10 (IP‐10) chemokine by human neutrophils

  1997cited by this paper
• Regulation of Chemokine Gene Expression in Human Endothelial Cells by Proinflammatory Cytokines and Borrelia burgdorferi

  1996cited by this paper
• Interleukin‐12: Murine Models of a Potent Antitumor Agent a

  1996cited by this paper
• Antitumor activity of interleukin 12 in preclinical models

  1996cited by this paper
• Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells.

  1996cited by this paper
• Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma.

  1996cited by this paper
• Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.

  1996cited by this paper
• Modulation of growth and apoptosis response in PC‐3 and LNCAP prostate‐cancer cell lines by FAS

  1996cited by this paper
• Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells.

  1996cited by this paper
• Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10.

  1996cited by this paper
• Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

  1996cited by this paper
• Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma.

  1996cited by this paper
• p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.

  1996cited by this paper
• Fas expression and function in normal and malignant breast cell lines.

  1996cited by this paper
• The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

  1996cited by this paper
• Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?

  1996cited by this paper
• Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.

  1996cited by this paper
• Immunoregulation by interleukin‐12

  1996cited by this paper
• Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.

  1996cited by this paper
• Decreased Fas antigen receptor expression in testicular tumor cell lines derived from polyomavirus large T-antigen transgenic mice.

  1996cited by this paper
• Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

  1995cited by this paper
• Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis.

  1995cited by this paper
• Human Mig chemokine: biochemical and functional characterization

  1995cited by this paper
• Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

  1995cited by this paper
• Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL- 12

  1995cited by this paper
• Fas-mediated cytotoxicity by freshly isolated natural killer cells

  1995cited by this paper
• The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha.

  1995cited by this paper
• Inhibition of angiogenesis in vivo by interleukin 12.

  1995cited by this paper
• The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*)

  1995cited by this paper
• Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts.

  1995cited by this paper
• A role for CD95 ligand in preventing graft rejection

  1995cited by this paper
• Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivo

  1995cited by this paper
• Expression of the Fas ligand in cells of T cell lineage.

  1995influential reference
• IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.

  1995cited by this paper
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

  1994cited by this paper
• Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.

  1994influential reference
• Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.

  1994cited by this paper
• Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12.

  1994cited by this paper
• Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

  1994cited by this paper
• Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.

  1994cited by this paper
• Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.

  1994cited by this paper
• Second signal activity of IL-12 on the proliferation and IL-2R expression of T helper cell-1 clone.

  1994cited by this paper
• Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

  1994cited by this paper
• Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.

  1994cited by this paper
• Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture.

  1993cited by this paper
• Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo.

  1993cited by this paper
• Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

  1993cited by this paper
• Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes.

  1993cited by this paper
• Lethal effect of the anti-Fas antibody in mice

  1993cited by this paper
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors

  1993cited by this paper
• Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

  1992cited by this paper
• IL-12 receptor. II. Distribution and regulation of receptor expression.

  1992cited by this paper
• Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.

  1992cited by this paper
• Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.

  1991cited by this paper
• The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis.

  1991cited by this paper
• Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers

  1991cited by this paper
• A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines.

  1990cited by this paper
• Monoclonal antibody-mediated tumor regression by induction of apoptosis.

  1989cited by this paper
• Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

  1989cited by this paper
• Van Damme A.

  1986cited by this paper
• Synergy between recombinant interleukin 2 (rIL 2) and IL 2-depleted lymphokine-containing supernatants in facilitating allogeneic human cytolytic T lymphocyte responses in vitro.

  1986cited by this paper
• γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

  1985cited by this paper
• Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues.

  1984cited by this paper
• Biological activity of recombinant human interleukin-2 produced in Escherichia coli.

  1984cited by this paper

• CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity

  2024cites this paper
• Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low‐Concentration Collagen‐Based Bioinks

  2023cites this paper
• Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy

  2021cites this paper
• A low carbohydrate diet containing soy protein and fish oil reduces breast but not prostate cancer in C3(1)/Tag mice.

  2021cites this paper
• Impact of IL-12 in Cancer.

  2017cites this paper
• Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.

  2014cites this paper
• Interleukin 12: still a promising candidate for tumor immunotherapy?

  2014cites this paper
• Collapse of the tumor stroma is triggered by IL-12 induction of Fas.

  2013cites this paper
• HUMAN ENDOGENOUS RETROVIRUS K AS A NOVEL TUMOR-ASSOCIATED ANTIGEN FOR DEVELOPMENT OF AN OVARIAN CANCER VACCINE

  2012cites this paper
• Plasma Mediated Molecular Delivery

  2010cites this paper
• Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI‐124 in a mouse melanoma tumor model

  2008cites this paper
• Biological therapy for pediatric malignancy: Current perspectives

  2008cites this paper
• Surgery as a Risk Factor for Breast Cancer Recurrence and Metastasis: Mediating Mechanisms and Clinical Prophylactic Approaches

  2007cites this paper
• Immunotherapy of cancer by IL-12-based cytokine combinations

  2007cites this paper
• Wirkung immunstimulatorischer Gentherapie auf das hepatozelluläre Karzinom in der Ratte

  2007cites this paper
• Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma.

  2006cites this paper
• Cancer vaccines: preclinical studies and novel strategies.

  2006cites this paper
• Tumor growth or regression: powered by inflammation

  2006cites this paper
• Multicolor Fluorescence-Based Approaches for Imaging Cytokine-Induced Alterations in the Neovascularization, Growth, Metastasis, and Apoptosis of Murine Neuroblastoma Tumors

  2006cites this paper
• Prophylaxis against carcinogenesis in three kinds of unestablished tumor models via IL12-gene-engineered MSCs.

  2006cites this paper
• Induction of protective immunity to RM‐1 prostate cancer cells with ALVAC‐IL‐2/IL‐12/TNF‐α combination therapy

  2006cites this paper
• Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy.

  2006cites this paper
• Oncolytic herpes simplex virus vector therapy of breast cancer in C3(1)/SV40 T-antigen transgenic mice.

  2005cites this paper
• Local interleukin-2 and interleukin-12 therapy of bovine ocular squamous cell carcinomas.

  2005cites this paper
• Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model.

  2005cites this paper
• Fas Ligand and TNF-Related Apoptosis-Inducing Ligand Induction on Infiltrating Lymphocytes in Bladder Carcinoma by Bacillus Calmette-Guérin Treatment

  2005cites this paper
• The promise of genetically engineered mice for cancer prevention studies

  2005cites this paper
• Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response.

  2005cites this paper
• Treatment of Relapsed and Refractory Neuroblastoma

  2005cites this paper
• Solid Tumors-role of biological agents in therapy

  2005cites this paper
• Treatment with IL-2 and IL-12 inhibits tumour cell division in SL2 lymphoma.

  2004cites this paper
• Effects of Combined Granulocyte–Macrophage Colony-Stimulating Factor (GM-CSF), Interleukin-2, and Interleukin-12 based Immunotherapy against Intracranial Glioma in the Rat

  2004cites this paper
• Antibody-cytokine fusion proteins: innovative weapons in the war against cancer

  2004cites this paper
• Chemoimmunotherapy of murine mammary adenocarcinomas.

  2004cites this paper
• Development and Characterization of a Progressive Series of Mammary Adenocarcinoma Cell Lines Derived from the C3(1)/SV40 Large T-antigen Transgenic Mouse Model

  2004cites this paper
• Regulation of Tumor Progression by Anti-Neoplastic T Cell Responses

  2004cites this paper
• Mammary Gland Cancer

  2004cites this paper
• Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

  2003cites this paper
• Mullerian Inhibiting Substance Promotes Interferon γ-induced Gene Expression and Apoptosis in Breast Cancer Cells*

  2003cites this paper
• Mullerian inhibiting substance promotes interferon gamma-induced gene expression and apoptosis in breast cancer cells.

  2003cites this paper
• Vaccines and Immunostimulants

  2003cites this paper
• The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.

  2003cites this paper
• Biology of FasL.

  2003cites this paper
• The Use of Cytokine Knockout Mice in Cancer Research

  2003cites this paper
• Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.

  2003cites this paper
• Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools

  2003influential citation
• Immunocytokines: amplification of anti-cancer immunity

  2003cites this paper
• Interleukin-2 and its receptor complex (α, β and γ chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study

  2003cites this paper
• Pre-Clinical Applications of Transgenic Mouse Mammary Cancer Models

  2002cites this paper
• Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity.

  2002cites this paper
• Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.

  2002cites this paper
• Gene Expression of B16F10 Induced by Treatment with 5-aza-2'-deoxycytidine

  2002cites this paper
• IL-12/IL-2 combination cytokine therapy for solid tumours: translation from bench to bedside

  2002cites this paper
• Administration of either anti-CD40 or interleukin-12 following lethal total body irradiation induces acute lethal toxicity affecting the gut.

  2002cites this paper
• Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2).

  2001cites this paper
• Spontaneous adenocarcinoma mouse models for immunotherapy.

  2001cites this paper
• Primary Hepatocytes from Mice Treated with IL-2/IL-12 Produce T Cell Chemoattractant Activity that Is Dependent on Monokine Induced by IFN-γ (Mig) and Chemokine Responsive to γ-2 (Crg-2)1

  2001cites this paper
• IFN-gamma and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy.

  2001cites this paper